RecruitingNCT05697861
Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
Long-Term Follow-Up of Subjects Treated With NTLA-2001
Sponsor
Intellia Therapeutics
Enrollment
72 participants
Start Date
Jul 10, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- A subject has completed or discontinued from an Intellia-sponsored clinical study in which a complete or partial dose of NTLA-2001 was received.
- A subject has provided informed consent for the LTFU study.
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05697861